To investigate the pathogenesis of macroglobulinemia in the tropical splenomegaly syndrome (TSS), we assessed the functional activity of B lymphocytes and T cell subsets in a pokeweed mitogen-driven assay of immunoglobulin synthesis. Mononuclear cells from patients with TSS produced more IgM than cells from village or from distant controls. This appeared to result from a decrease in the number and/or activity of suppressor T cells of the T8S phenotype. The lack of functional suppressor T lymphocytes was associated with the presence in sera from patients with TSS of IgM antibodies that specifically killed T8+, 9.3-, 60.1+ T cells from normal donors. These results support the hypothesis that macroglobulinemia in TSS results from defective immunoregulatory control of B cell function, and that this may be caused by lysis of suppressor T cells by specific lymphocytotoxic antibodies produced by patients with this syndrome.
Introduction
Tropical splenomegaly syndrome (TSS)' is a term used to describe a morbid condition in adult long-term residents of malarious areas characterized by massive splenomegaly and markedly elevated levels of serum IgM that generally improves with prolonged malaria chemosuppression (1, 2) . It has been proposed that splenomegaly in this syndrome results from chronic stimulation of splenic reticuloendothelial cells engaged in the clearing of high molecular weight immune complexes and IgM aggregates produced in excessive amounts because of unbridled immune responses to malarial antigens or mitogens (2) (3) (4) .
Because not all adults living in malarious areas develop TSS, this hypothesis implies a defect in the regulation of immune responses in patients with this syndrome. We previously observed imbalances in the relative proportions of imDr. Wadee is the recipient of a fellowship from the South African Research Council. Address reprint requests to Dr. Piessens at the Harvard School of Public Health. Received for publication 21 September 1984 and in revised form 6 February 1985. munoregulatory thymus-dependent (T) lymphocytes in peripheral blood of patients with TSS, a finding that is consistent with this hypothesis (5) . However, these studies failed to document that such phenotypic changes resulted in functional abnormalities that could account for the marked hyperproduction of IgM in patients with TSS. These studies also did not address the pathogenesis of the apparent imbalance in the immunoregulatory T cells in this syndrome.
We now have examined the functional activity of various lymphocyte populations from patients with TSS and report here that these individuals lack functional suppressor T lymphocytes. Our studies suggest that this may be caused by the effect of lymphocytotoxic antibodies elicited during this syndrome. These findings provide a possible explanation for the marked polyclonal macroglobulinemia that is characteristic of TSS.
Methods
Blood donors. In a previous study, we enumerated circulating T and B lymphocytes in a large number of inhabitants of Robek, Flores, Indonesia, where TSS is common and in a group of residents of Jakarta, Java, Indonesia, where malaria is not transmitted (5) . This information was used to select blood donors for the present study. All participants were adult volunteers assessed clinically and parasitologically as previously described (5 (8) . In brief, cells from normal donors (see below) were labeled with Na5tCrO4 (New England Nuclear, Boston, MA) and washed extensively. The assay was performed by adding into microfuge tubes (PD-2 tubes, Luckham Ltd., Burgess Hill, United Kingdom) 50 jd of serum and 50 ul of cells (5 X 106/ml).
After 30 min of incubation at room temperature, 50 Ml of fresh rabbit complement (Cedarlane, Ontario, Canada) was added. The tubes were then incubated at 370C for 6 h. (250 MAl of TCM was added to the cell suspensions after 2 h of culture.) At the end of the incubation period, 100 Ml of supernatant was removed from the test tube, and placed into a second tube. Radioactivity in the paired tubes was measured in a Packard gamma counter (Packard Instrument Co., Inc., Downers This formula expresses the amount of radioactivity released in culture supernatant (the numerator) as a percentage of the total (released and cell-associated) amount of radioactivity present in each assay tube (the denominator). This minimizes the effect of minor variations that inevitably occur when a stock suspension of radiolabeled targets is dispersed into a large number of assay tubes (8 (Table IV) . In contrast, IgG production in the same cultures was suppressed to the same extent by concanavalin A-activated MNC from TSS donors and villager controls (Table IV) . Similar results were obtained when induced suppressor cells were co-cultured with syngeneic cells from the same TSS donor. In four experiments of this kind, IgM production was inhibited 8±14% (mean±SD), whereas IgG production was decreased by 62-89%.
Lymphotoxic activity ofserafrom patients with TSS. Taken together with our previous findings, the results just described indicated that patients with TSS lack circulating T8' lymphocytes that function as suppressor cells of immunoglobulin synthesis. Because of the polyclonal nature of the hyperglobulinemia that characterizes this syndrome, we next examined the possibility that patients with TSS develop "autoantibodies" to suppressor T lymphocytes. This appeared to be the case. Sera from patients with TSS induce significantly more t1Cr release than sera from the two control groups (P < 0.05 by t test).
Sera from patients with TSS and decreased levels of circulating T8' cells were cytotoxic for lymphocytes from normal donors, whereas sera from distant or village control donors with normal levels of T8' cells were not (Table V) .
The lymphocytotoxic activity appeared to be a complementfixing IgM antibody, (Fig. 2) . Studies to identify the nature of the target of the TSS lymphotoxin revealed that mitogenactivated T8' cells were more susceptible to the lytic action of this antibody than nonactivated T8' cells (Table VI) and that B lymphocytes were not killed by TSS sera (results not shown).
Within the T8' population, lymphocytes with the 60.1+ or 9.3-phenotype were killed by this antibody, whereas the reciprocal 60.1-or 9.3+ population was not (Fig. 3) . Thus, sera from patients with TSS appeared to react with the subset of T8' lymphocytes that bears phenotypic markers of suppressor T cells.
To confirm this tentative conclusion, we compared immunoglobulin production by equal numbers of MNC from normal donors previously treated in vitro with complement plus pooled sera from TSS or village control donors. Pretreatment with TSS sera markedly increased IgM production without affecting IgG production (Table VII) .
Discussion
Hyperelevation of serum 1gM levels is a major characteristic of TSS. This finding cannot be explained solely on the basis of elevated levels of IgM antibodies to specific malarial antigens: a large proportion of serum IgM reacts with other, mostly unidentified antigens (1, 2) . This observation has prompted the hypothesis that the polyclonal gammopathy of TSS results from hyperproduction of immunoglobulins (mostly IgM) by B lymphocytes activated by malarial antigens or mitogens. This, in turn, is believed to reflect an imbalance in the number and/or activity of immunoregulatory T lymphocytes in patients with this syndrome (4, 5) . In a previous study, we found that Indonesian patients with TSS lacked circulatory lymphocytes of the T8' (suppressor/cytotoxic) phenotype (5 Although our studies indicate that actual destruction of suppressor cells may contribute to the immunoregulatory abnormalities associated with TSS, we cannot rule out the possibility that the anti-T cell antibodies that we describe could operate in vivo by noncytotoxic mechanisms, e.g., by altering lymphocyte traffic or homing patterns. In this context, it is of interest that sera from patients with systemic lupus erythematosus contain both cytotoxic antibodies to suppressor T cells and antibodies that interfere with suppressor cell activity by a noncytolytic mechanism (13, 14) . Sequestration of T cells in spleens has been invoked to explain the temporary decreases in circulating T cells during acute malaria attacks (15, 16) . Cold-reactive lymphocytotoxins are present in sera from such patients (17) . However, the relative percentage of T and B cells in splenic aspirates of patients with TSS is reported to be similar to that in uninfected controls (18) . Thus, whether the immunoregulatory dysfunction in TSS is caused by cytolytic or noncytotoxic effects of antisuppressor T cell antibodies remains an unsettled question, but current evidence favors the former possibility.
Polyclonal macroglobulinemia is observed during many parasitic infections, most notably in African trypanosomiasis, chronic malaria, and lepromatous leprosy (5, 19, 20) . It is often assumed that this results from nonspecific stimulation of host immunity by mitogenic products of the infecting organisms (21, 22) . However, both in leprosy (20) and (as reported here) in TSS, abnormal suppressor T cell activity appears to be the prime cause of hyperproduction of immunoglobulins. This suggests that such mitogens may preferentially activate certain subpopulations of lymphocytes. This appears to be the case in brugian filariasis (Wadee, A. A., and W. F. Piessens, submitted for publication).
Two of the changes found in the present study, IgM lymphocytotoxic antibodies and deficient concanavalin Ainduced suppressor activity, have been described in patients with acute malaria, who typically develop transient splenomegaly (17, 23, 24 ). Thus, it is possible that similar immunologic imbalances contribute to the transient splenomegaly in patients with acute malaria and the persistent splenic enlargement in patients with TSS. Why then do only a minority of patients with malaria develop TSS? A major difference between patients with this syndrome and those with classic malaria is the absence of functional immunity in the former (25, 26) . Thus, one would expect that immunologic disturbances such as the ones we describe would be transient in individuals with acute malaria who develop resistance to the parasite and thereby eliminate the cause of the abnormalities, but would persist in patients with TSS who fail to do so. Reversal of immune aberrations in persons with TSS treated with antimalarials is consistent with this point of view (1, 2, 5) .
Our findings in TSS are similar to those reported in systemic lupus erythematosis by Morimoto et al. (13) . In both diseases, autoantibodies to multiple self antigens arise in the context of polyclonal activation of host immunity (27, 28) . Marked differences exist in the course of parasitic infections in normal mice vs. mice with a genetic predisposition to autoimmunity (29) . Because only a minority of residents of malarious areas develop TSS, it is tempting to speculate that this syndrome occurs only in persons who are intrinsically prone to autoimmune diseases. This highly speculative interpretation of the findings we report remains to be tested by long-term prospective studies on residents of areas where TSS is common. Studies designed to identify risk factors that allow the development of this syndrome are in progress.
